# A Study of Ustekinumab Treatment in Children With Crohn's Disease

> **NCT05242458** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 545 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT05242458
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2023-05-22
- **Final completion:** 2023-05-22
- **Target enrollment:** 545 (ACTUAL)
- **Last updated:** 2025-05-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05242458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05242458, "A Study of Ustekinumab Treatment in Children With Crohn's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05242458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*